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Perinatal asphyxia (PA) remains as one of the most important causes of short-
term mortality, psychiatric and neurological disorders in children, without an effective
treatment. In previous studies we have observed that the expression of different
neurodegenerative markers increases in CA1 hippocampal area of 4-months-old male
rats born by cesarean section and exposed for 19 min to PA. We have also shown that a
late treatment with 17β estradiol (daily dose of 250 µg/kg for 3 days) was able to revert
the brain alterations observed in those animals. Based on these previous results, the
main aim of the present study was to explore the mechanism by which the estrogenic
treatment is involved in the reversion of the chronic neurodegenerative conditions
induced by PA. We demonstrated that estradiol treatment of adult PA exposed animals
induced an increase in estrogen receptor (ER) α and insulin-like growth factor receptor
(IGF-1R) protein levels, an activation of the phosphatidylinositol 3-kinase/Akt/glycogen
synthase kinase 3 beta/β-catenin signaling pathway and an increase in Bcl-2/Bax ratio
in the hippocampus in comparison to PA exposed animals treated with vehicle. Taking
together, our data suggest that the interaction between ERα and IGF-IR, with the
subsequent downstream activation, underlies the beneficial effects of estradiol observed
in late treatment of PA.
Keywords: hippocampus, neuroprotection, western blot, signaling pathway, neuronal survival
INTRODUCTION
During perinatal lifetime, different factors selectively impair certain aspects of neurodevelopment,
having long-lasting deleterious consequences in adult brain functioning (Basovich, 2010).
Developing brains are susceptible to hypoxia-ischemia insults (obstetrical problem known as
PA), which are associated with neurodevelopmental disorders (NDDs) (van Handel et al., 2007).
Abbreviations: Akt, serine/threonine protein kinase; ER, estrogen receptor; GSK-3, glycogen synthase kinase 3; IGF-IR,
insulin-like growth factor-I receptor; PA, perinatal asphyxia; PI3K, phosphoinositide 3-kinase.
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The combination of an elevated vulnerability of the immature
brain and the long-consequences in life quality, together with
the limited availability of therapeutic tools to attenuate brain
damage, supports the search for new preventive and therapeutic
strategies (Manthey and Behl, 2006). During the last decade,
the neuroprotective effects of the ovarian hormone 17β estradiol
has been studied by several groups in different experimental
pathological conditions (Bourque et al., 2009; Garcia-Segura
and Balthazart, 2009; Kipp and Beyer, 2009; Kruse et al., 2009;
Lebesgue et al., 2009; Pike et al., 2009; Suzuki et al., 2009).
Previous studies from our laboratory showed that the ovarian
hormone is able to reduce, in adult animals, chronic reactive
astrogliosis and neuronal alterations in the hippocampus caused
by PA (Saraceno et al., 2010). However, it is still unknown how
estradiol triggers these reparative effects.
Most of the estradiol neuroprotective effects in the brain
are mediated by activating several complementary signaling
pathways by ERs (Arevalo et al., 2015). Classical ERs are
transcription factors and two main isoforms, ERα and ERβ, have
been characterized in mammals (Walter et al., 1985; Kuiper
et al., 1996). Besides the ligand-binding domain, those ERs
could be regulated by kinases activated by signaling pathways
of several growth factors, such as IGF-1, due to their second
activation domain (Ma et al., 1994; Mendez and Garcia-Segura,
2006). Finally, membrane-associated ERα and ERβ and non-
classical ERs, such as G protein-coupled ER (GPER), also
allow communication with the signaling cascade of other
neuroprotective molecules (Ruiz-Palmero et al., 2013; Arevalo
et al., 2015). Thus, considering the neuroprotective mechanisms
of estradiol and ERs, it is important to recognize ERs as a key
convergent point for estradiol signaling and the signaling of
others neuroprotective factors.
Parallel neuroprotective mechanisms could be triggered in
the brain by the activation of ERα, ERβ, and GPER. Moreover,
ER activation also involves interactions with the protective
pathways induced by other neuroprotective factors. On this
regard, estradiol signaling and IGF-1 receptor (IGF-1R) signaling
interact through ERα, allowing the formation of a multimolecular
complex composed by ERα, IGF-1R and components of the
IGF-1R signaling pathway such as, PI3K, Akt, and GSK3β
(Mendez et al., 2003; Cardona-Gomez et al., 2004). This
ERα/IGF-1R signaling interaction allows the regulation of PI3K-
Akt-GSK3β-β-catenin signaling pathway by estradiol in the
brain (Cardona-Gomez et al., 2004; D’Astous et al., 2006). It
has been shown that inhibition of PI3K signaling abolishes
the neuroprotective actions of estradiol in global cerebral
ischemia and experimental stroke models (Jover-Mengual et al.,
2010; Yang et al., 2010). Moreover, previous studies showed
that estradiol and IGF-1 have a synergistic effect on Akt
phosphorylation (Cardona-Gomez et al., 2002a), which regulates
several transcription factors involved in the control of neuronal
survival (Kane et al., 1999; Pugazhenthi et al., 2000). In addition,
Akt activation by estradiol inhibits GSK3 activity promoting
neuronal survival (Cardona-Gomez et al., 2004), inducing the
activation of neuronal survival pathways (Cross et al., 1995) and
decreasing tau protein phosphorylation (Cardona-Gomez et al.,
2004).
Growing body of evidence postulates that the neuroprotective
relevance of ERs depends on the implemented pathological
model (Simpkins et al., 2012). Although we partially know
how estradiol exerts neuroprotective actions in focal or global
ischemia models when it was administrated before or shortly
after the induction of the brain damage (Dubal et al., 2001;
Carswell et al., 2004; Miller et al., 2005; Suzuki et al., 2007),
the mechanism by which the hormone exerts reparative actions
in the brain of adult animals exposed to PA (Saraceno et al.,
2010) remain to be explored. Our main goals in the present study
were to determine: (i) whether PA could affect the expression of
ERs and their downstream signaling pathway activation, and (ii)
whether estradiol treatment in adult animals exposed to PA exerts
reparative actions by activating the neuroprotective mechanisms
of ERs in parallel with the protective pathways induced by IGF-1.
MATERIALS AND METHODS
Animals
All procedures involving animals were approved by the
Institutional Animal Care and Use Committee at the University
of Buenos Aires (CICUAL, #4091/04) and conducted according
to the principles of the Guide for the Care and Use of
Laboratory Animals (Animal Welfare Assurance, A-3033-01
protocol #S01084). Pregnant Sprague Dawley female rats and
their male offspring were used in this study. Female rats in
the 15th day of pregnancy were placed in individual cages
and maintained on a 12:12 h light/dark cycle in a controlled
temperature (21 ± 2◦C) and humidity (65 ± 5%) environment.
The animals had access to food (Purina chow) and tap water ad
libitum. One group of animals (n = 10) was used as surrogate
mothers, another group (n = 12) was assigned to PA procedures,
and the remaining animals (n = 8) were the mothers of the control
pups.
Induction of Asphyxia
Twelve full-term pregnant rats on gestational day 22, were
anesthetized (Saraceno et al., 2010), rapidly decapitated and the
uterus horns were isolated through an abdominal incision and
placed in a water bath at 37◦C for 19 min (sub-severe PA)
(Bjelke et al., 1991; Capani et al., 2001; Saraceno et al., 2010).
Following PA, the uterine horns were rapidly opened, the pups
were removed, the amniotic fluid was cleaned and the pups
were stimulated to breathe by performing tactile intermittent
stimulation with pieces of medical wipes for a few minutes until
regular breathing was established. The umbilical cord was ligated
and the animals were left to recover for 1 h under a heating lamp.
When their physiological conditions improved, they were given
to surrogate mothers that had delivered normally within the last
24 h. The different groups of pups were marked and mixed with
the surrogate mothers’ normal litters (control animals that were
left undisturbed). We maintained litters of 10 pups with each
surrogate mother. Rats were weaned at 21 days of age and housed
in groups of four animals per cage through the experiment. Only
male animals were retained for the present study, while female
animals were used for other research projects.
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Estradiol Treatment
Thirty-two adult male rats were i.p. injected, 117 days after PA,
with 17β estradiol (water soluble, E4389, Sigma, St. Louis, MO,
United States; 250 µg/kg) or vehicle (0.9% saline solution) as
described previously (Saraceno et al., 2010). The injections were
repeated daily for 3 days consecutively (up to 119 days after
PA) (Figure 1). Animals were distributed in four experimental
groups: (i) control animals injected with vehicle, (ii) control
animals injected with 17β estradiol, (iii) animals submitted to PA
and injected with vehicle, and (iv) animals submitted to PA and
treated with 17β estradiol.
Immunoblotting
Sixteen male animals (120 days old; n = 4 per group) were
killed by decapitation and the hippocampus was dissected.
Subcellular fractionation was performed as previously described
(Cardona-Gomez et al., 2002a,b). Briefly, dissected hippocampus
was homogenized in a Dounce homogenizer with 1 ml of
homogenization buffer (20 mM Tris-HCl, pH 7.4, 50 mM NaF,
1 mM Na3VO4, 1 mM EDTA, 1.25 µg/mL pepstatin A, 10 µg/mL
leupeptin, 2.5 µg/mL aproptionin, 0.5 mM PMSF) containing
320 mM sucrose. Then, the homogenate was centrifuged at
1000 × g for 10 min and the supernatant was centrifuged at
16000 × g for 15 min to obtain the cytoplasmic cellular fraction.
Protein concentration was estimated by Bradford technique
(Bradford, 1976). The subcellular fractions were stored at−80◦C.
Western blot analysis was carried out using cytosolic fractions
separated on 8, 10, or 12.5% SDS-PAGE, in accordance with the
molecular weight of the interested protein. Samples containing
20 µg of protein from each groups were applied to each
lane. After electrophoresis (120 V for 90 min), proteins were
transferred to polyvinylidene difluoride (PVDF) membrane
for 2 h at 260 mA as described previously (Dunah et al., 1996).
Cytoplasmic cellular fractions (n = 4 per group) were incubated
overnight at 4◦C with the following primary antibodies:
FIGURE 1 | Schematic illustration of the experimental design. Dam rats that
delivered no more than two pups (vaginally delivered controls, CTL) were
hysterectomized, the uterus horns were immersed in a water bath at 37◦C
during 19 min [pups born by cesarean section plus asphyxia (PA)].
Intraperitoneal (i.p.) administration of 17β estradiol (250 µg/kg) or vehicle
(0.9% saline solution) started 117 days after PA and it was repeated daily for
3 days consecutively (up to 119 days after PA). Animals were distributed in
four experimental groups: (i) control animals injected with vehicle, (ii) control
animals injected with 17β estradiol, (iii) animals submitted to PA and injected
with vehicle and, (iv) animals submitted to PA and treated with 17β estradiol.
anti-GPER (1:1000, mouse-IgG, Sigma-Aldrich), anti-ERα
(mouse-IgG, 1:500, Sigma-Aldrich), anti-ERβ (mouse-IgG,
1:800, Sigma-Aldrich), anti-IGF-1R (rabbit-IgG, 1:1000, Santa
Cruz), anti-Akt (1:1000, mouse-IgG, Cell Signaling), anti-GSK3-
beta (1:500, mouse-IgG, Abcam), anti-GSK3 beta-phospho
S9 (GSK3β-p-Ser, 1:500, rabbit-IgG, Abcam), anti-phospho-
Akt-Thr308 (p-Akt, 1:1000, rabbit-IgG, Cell Signaling),
anti PI3 (1:2000, mouse-IgG, Santa Cruz), anti β-catenin
(1:1000, rabbit-IgG, Abcam). We used anti glyceraldehyde-
3-phosphate dehydrogenase (GAPDH, 1:1000, rabbit-IgG,
Sigma-Aldrich) as loading control. Blots were rinsed three
times in PBS with 0.5% Tween-20 buffer (PBST), and then
incubated with the corresponding horseradish peroxidase
(HRP)-conjugated secondary antibody (1:1000, Bio-Rad) for
2 h at RT. Immunoreactive bands were detected using an
ECLTM Western Blotting Analysis System (AmershamTM,
GE/Healthcare). Films were scanned and the optical density of
protein bands was quantified using Gel Pro Analyzer software
3.1.00.00 (Media Cybernetics).
Immunostaining, Confocal Microscopy,
and Morphometric Analysis
Sixteen male animals (120 days old; n = 4 per group) were
anesthetized with chloral hydrate (28% w/v; 0.1 ml/100 g
body weight), and perfused intracardially with 4%
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4.
Brains were removed and post-fixed in the same fixative
solution for 2 h at room temperature and then immersed
overnight at 4◦C in 0.1 M phosphate buffer, pH 7.4. Coronal
hippocampal sections (40 µm thick) were obtained using
a Vibratome (VT 1000 S, Leica Microsystems, Wetzlar,
Germany).
Immunofluorescence was performed on free floating sections
under moderate shaking. Tissue sections were blocked for 30 min
in phosphate-buffered saline (PBS) containing 0.3% bovine
serum albumin (BSA; Sigma, St. Louis, MO, United States)
and 0.3% Triton X-100. Sections were incubated overnight
at 4◦C with a rabbit polyclonal anti-GFAP antibody (1:2000,
Sigma, St. Louis, MO, United States) and a mouse monoclonal
anti-ERα antibody (mouse-IgG, 1:500, Sigma-Aldrich). After
washing in buffer, tissue sections were incubated for 2 h at
room temperature with Alexa 594 goat anti-rabbit IgG (1:200,
Molecular Probes) and Alexa 488 goat anti-mouse IgG (1:200,
Molecular Probes). Sections were counterstained with DAPI
(Vector Laboratories, Inc., Burlingame, CA, United States)
to label cell nuclei and mounted with Vectashield mounting
medium. As specificity controls, some sections were incubated
with the secondary antibody only. Under these conditions no
immunostaining was observed. In order to minimize inter-
assay variations, samples from all experimental groups were
processed in parallel. Fluorescence was acquired on a commercial
inverted confocal SPT-5 microscope (Leica Microsystems), with
magnification of 63X oil DIC with excitation at 405, 488,
561 nm. Percentage of reactive area and colocalization analysis
were estimated using Image J Program (Image J1.41o, NIH,
United States). Briefly, images were obtained separately for each
channel and analyzed. Single-channel images were thresholded
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and a binary image was created from each thresholded single-
channel image. We measure the percentage of pixels in the
selection that have been highlighted in red as an indicator of the
percentage of reactive area. For colocalization analysis, binary
images were then added together to display overlap, and a
third binarized image of strict pixel overlap (colocalization) was
used for analysis. Percentage of colocalization was calculated as
colocalized ERα/GFAP divided by the total number of GFAP
positive cells.
Statistical Analysis
Material from eight rats was analyzed for each experimental
group and for each parameter studied (total n = 32). All
statistical analyses were performed by two-way analysis of
variance (ANOVA) with birth condition (CTL and PA) and
treatment (Vhi and 17β) as the main factors. When interaction
effects were significant, analyses of the simple effects were
carried out by post hoc comparisons using Student’s t-test (two-
tailed) adjusted by Bonferroni correction. In any case neither
the assumption of normal distribution (Shapiro–Wilk test) nor
equality of variances (Levene’s test) was rejected. Results were
expressed as the mean ± SEM. Differences with a p < 0.05 were
considered to be significant. Statistical analyses were performed
using the GraphPad Prism 5.03 statistical package for Windows
(GraphPad software).
RESULTS
Estradiol Increased the Expression of
ERα in the Hippocampus of Adult Male
Rats Subjected to PA
As shown in Figure 2, the protein levels of ERα, ERβ, and
GPER were not significantly different (p > 0.05) between the
animals subjected to PA and injected with vehicle (PA-Vhi) and
the control animals injected with vehicle (CTL-Vhi). Estradiol
treatment induced a significant increase in the protein levels of
ERα in PA exposed animals (PA-17β) (Figure 2), but did not affect
the expression of ERβ and GPER (Figure 2).
Immunolocalization studies by confocal microscopy revealed
ERα immunoreactivity in astrocytes in both vehicle and estradiol
injected animals. The percentage of colocalization of ERα and
GFAP immunoreactivities was increased in PA exposed animals
FIGURE 2 | Hippocampal ERs expression analysis in adult male rats subjected to PA or treatment. Immunoblots were analyzed using different antibodies against
GPER, ERβ, ERα, and GAPDH (loading control) in cytoplasmic fractions (n = 4 per group). The figure shows that PA does not induce any significant change
regarding ERs and GPER level expression compared to control animals treated with vehicle or estradiol. In contrast, ERα protein level increased after the treatment
with estradiol respect to asphyctic animals injected with vehicle and control animals treated with vehicle (!p < 0.05 PA-17β vs. PA-Vhi; ∗∗p < 0.01 PA-17β vs.
CTL-Vhi after two-way ANOVA and Bonferroni post hoc test). Error bars represent the mean ± SEM.
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injected with vehicle compared to control animals injected
with vehicle. This suggests an induction in the expression
of ERα in astrocytes by PA. The treatment with estradiol
induced an increased ERα cytoplasmic immunoreactivity in
CA1 pyramidal neurons and increases the percentage of ERα
immunoreactive area in control and PA exposed animals
(Figure 3).
Estradiol Reverts the Effects of PA on
IGF-1R/PI3-K/Akt/GSK3/β-Catenin
Signaling Pathway
Some of the estradiol effects on the brain are mediated by
the interaction of ERs with the signaling of growth factors,
such as IGF-1. We observed that PA decreased the expression
of IGF-1 receptor, an effect that was reverted by estradiol
treatment (Figure 4). Since estradiol treatment increased the
levels of IGF-1R and ERα in PA exposed animals, we decided to
study the effect of the hormone on the phosphatidyl inositol 3
kinase (PI3K) signaling pathway, which is downstream of IGF-
1R. PA exposed animals showed a significant decrease in the
protein levels of PI3K compared to the control groups (CTL-
Vhi and CTL-17β). Estradiol treatment increased the expression
of PI3K in PA exposed animals (PA-17β) to control levels
(Figure 4).
The PI3K enzyme promotes the phosphorylation of the serine-
threonine kinase enzyme Akt and its activation. In turn, Akt
phosphorylates and inhibits GSK3β, which regulates the levels
of β-catenin. No significant differences in total Akt and GSK3β
protein levels were found between the experimental groups
(Figure 4). However, PA induced a marked decrease in Akt
phosphorylation (pAkt), determined as the ratio between its
phosphorylation level at Ser473 and total Akt level (Figure 4).
Estradiol treatment significantly reversed the downregulation of
pAkt levels induced by PA (Figure 4). Moreover, PA decreased
the levels of phosphorylated GSK3β (pGSK3β) and the levels
of β-catenin and these effects of PA were reverted by estradiol
(Figure 4). Together, all these findings suggest that PA induced
a permanent downregulation of the PI3-K/Akt/GSK3/β-catenin
survival pathway in the hippocampus and that estradiol
treatment recovers this pathway.
Estradiol Reverts the Effect of PA on
Bcl-2/Bax Ratio
Given the changes in Akt caused by PA and estradiol treatments,
we evaluated the levels of Bcl-2 and Bax. PA induced a decrease
in Bcl-2 protein levels. In contrast, estradiol induced a significant
increase in Bcl-2 protein expression. Bax protein levels were
unaffected by the treatments (Figure 5). Together, all these
findings indicate that PA decreased the Bcl-2/Bax ratio, while
FIGURE 3 | ERα immunoreactivity is modified by PA and estradiol treatment. Confocal microscope images of GFAP (red) and ERα (green) immunostaining from the
striatum radiatum of CA1 hippocampal area (n = 4 per group). Percentage of ERα immunoreactive area was increased by estradiol in both control and estradiol
treated animals. !! CTL-Vhi vs. CTL-17β; ∗∗p < 0.01, PA-Vhi vs. CTL-17β; ++p < 0.01, PA-Vhi vs. PA-17β after two-way ANOVA and Bonferroni post hoc test.
Moreover, colocalization analysis revealed an increase in ERα immunoreactivity in astrocytes from PA exposed animals injected with vehicle respect to control group
injected with vehicle and PA exposed animals treated with estradiol. Error bars represent the mean ± SEM. ∗p < 0.05, PA-Vhi vs. CTL-Vhi; +p < 0.05, PA-Vhi vs.
PA-17β after two-way ANOVA and Bonferroni post hoc test. Scale bar: 10 µm.
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FIGURE 4 | Perinatal asphyxia affects the IGF-1R/PI3-K/Akt/GSK3/β-catenin signaling pathway. Immunoblots were analyzed using different antibodies against
IGF-IRB, PI3K, Akt, pAkt, GSK3B, pGSK3B, β-catenin, and GAPDH (loading control) in cytoplasmic fractions (n = 4 per group). The figure shows that PA affected the
entire signaling pathway inducing a decrease in the protein expression/phosphorylation respect to control group injected with vehicle or estradiol (IGF-IRB: ∗p < 0.05
PA-Vhi vs. CTL-Vhi; PI3K: ∗∗p < 0.01 PA-Vhi vs. CTL-Vhi, !!p < 0.01 PA-Vhi vs. CTL-17β; pAkt/Akt: ∗p < 0.05; PA-Vhi vs. CTL-Vhi, PA-Vhi vs. CTL-17β;
pGSK3B/GSK3B: ∗∗p < 0.01 PA-Vhi vs. CTL-Vhi, PA-Vhi vs. CTL-17β; β-catenin: ∗p < 0.05 PA-Vhi vs. CTL-Vhi, PA-Vhi vs. CTL-17β after two-way ANOVA and
Bonferroni post hoc test). Estradiol reverted most of the changes induced by PA (IGF-IRB: !p < 0.05 PA-Vhi vs. PA-17β; PI3K: +p < 0.05 PA-Vhi vs. PA-17β;
pAkt/Akt: !!p < 0.01 PA-Vhi vs. PA-17β; β-catenin: !p < 0.05 PA-Vhi vs. PA-17β after two-way ANOVA and Bonferroni post hoc test). Error bars represent the
mean ± SEM.
estradiol treatment significantly increased this ratio, suggesting
a rescue response against the asphyctic insult.
DISCUSSION
Our findings indicate that adult rats submitted to PA present
a decrease in the expression of IGF-1R, PI3K, β catenin, and
Bcl2 and a decreased phosphorylation of Akt and GSK3β in
the hippocampus. These changes observed in adult rats suggest
that PA induces a permanent alteration in hippocampal IGF-
1R signaling (Lee et al., 1996; Kartal et al., 2016). Interestingly,
estradiol administration to adult rats submitted to PA was
able to revert the decrease in the levels of IGF-1R, PI3K,
pAkt, β-catenin, and Bcl2 in the hippocampus, suggesting that
the IGF-1R/PI3K/Akt/GSK3β/β catenin signaling pathway is
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involved in the hormonal reversion of hippocampal neural
deficits caused by early brain damage (Saraceno et al., 2010).
These findings suggest potential new therapeutic targets for
neuroprotection in infants who suffer PA.
Previous studies have shown that ERα is critical to
determine the ability of physiological levels of estradiol to exert
neuroprotection (Dubal et al., 2001). ERα mRNA levels are
increased shortly after the induction of ischemic injury both
in the presence and absence of estradiol (Dubal et al., 1999).
In addition, estradiol induces the expression of IGF-1 (Kapur
et al., 1992; Michels et al., 1993) and IGF-1R (Cardona-Gómez
et al., 2000; El-Bakri et al., 2004) in the brain and activates the
signaling cascade of IGF-1R via ERα (Kahlert et al., 2000; Marin
et al., 2009). On the other hand, IGF-1R activation is essential for
several actions of estradiol in the brain, such as neuroprotection
in the hippocampus (Garcia-Segura et al., 2000). It has been
shown that estradiol induces the formation of a multimolecular
complex composed by ERα, IGF-1R and components of the
IGF-1R signaling pathway in the brain (Mendez et al., 2003;
Cardona-Gomez et al., 2004). This complex may be involved in
the synergistic activation of Akt by IGF-1 and estradiol in the
brain through ERα (Cardona-Gomez et al., 2002b).
Taken in consideration the previously discussed interaction
of ERα with IGF-1R signaling in the brain, our present results
may offer a mechanistic explanation for the reparative effects
of estradiol in the hippocampus of adult animals exposed
FIGURE 5 | Bcl-2/Bax ratio is affected by PA and estradiol treatment. Immunoblots were analyzed using different antibodies against Bcl-2, Bax, and GAPDH (loading
control) in cytoplasmic fractions (n = 4 per group). The figure shows that Bcl-2 expression was decreased under PA compared to control groups treated with vehicle
or estradiol, affecting the Bcl-2/Bax ratio. Estradiol treatment increased the expression of Bcl-2, reverting the effects of PA (∗p < 0.05; PA-Vhi vs. CTL-Vhi, PA-Vhi vs.
CTL-17β; !p < 0.05 PA-Vhi vs. PA-17β after two-way ANOVA and Bonferroni post hoc test). Error bars represent the mean ± SEM.
FIGURE 6 | Summary of the changes induced by PA and estradiol treatment in the IGF-1R signaling pathway. PA induced a decrease in IGF-1R, PI3K, β catenin,
and Bcl2 expression and a decrease in the phosphorylation of Akt and GSK3β in the hippocampus. Estradiol administration to adult rats submitted to PA was able to
revert these changes, restoring the protein levels to similar values to those seen in control animals.
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to PA. Thus, estradiol increased the expression of ERα in
the hippocampus of adult animals that were submitted to
PA. This may facilitate the activation of neuroprotective
signaling pathways mediated by ERα (Arevalo et al., 2015).
Indeed, estradiol restored the expression or phosphorylation
of components of the PI3K/Akt/GSK3β/β-catenin signaling
pathway that were decreased by PA. The restoration of this
signaling pathway by estradiol may have direct consequences
in the reparative process, including the reversion of dendritic
and cytoskeletal alterations (Saraceno et al., 2010). Indeed,
Akt activation regulates estradiol-induced synaptic plasticity
(Znamensky et al., 2003) and is involved in the neuroprotective
effects of the hormone (Zhang et al., 2001; Yu et al., 2004).
Moreover, Akt activation modulates GSK3β activity (Cardona-
Gomez et al., 2004), which regulates microtubule dynamics,
neuritic growth, synaptogenesis, and synaptic plasticity (Hall
et al., 2000). Therefore, estradiol regulation of GSK3β
phosphorylation in the hippocampus of PA exposed animals
may be involved in the reparative process. Furthermore,
sustained activation of GSK3β may result in degenerative damage
(Bhat et al., 2000), while its inhibition, regulated by estradiol
(Cardona-Gomez et al., 2004), is associated with the activation
of neuronal survival pathways in the hippocampus (Cross et al.,
1995).
In this regard, inhibition of GSK3β activity by the Wnt
signaling pathway has been shown to allow nuclear translocation
and transcriptional activity of β-catenin, whereas GSK3β
activation redirects β-catenin into the proteasome pathway
(Barth et al., 1997). On the other hand, the activation of Akt
by estradiol in the hippocampus of animals exposed to PA may
also affect the expression of molecules that regulate apoptosis.
Thus, we observed an increase in the relative concentration of
Bcl-2 and a decrease in Bax, affecting the Bcl-2/Bax ratio in the
hippocampus of PA exposed animals treated with estradiol. It has
been shown that Akt activation also promotes phosphorylation
of BAD, a member of the Bcl-2 family, and can suppress BAD-
induced cell death (del Peso et al., 1997). Furthermore, the
activation of Akt increases the activity of the Bcl-2 promoter,
and estradiol induces the expression of Bcl-2 in neurons (Garcia-
Segura et al., 1998; Pugazhenthi et al., 2000) by IGF-1R activation
in the adult brain (Cross et al., 1995). Thus, the increase in Bcl2
expression in the hippocampus of PA exposed rats treated with
estradiol may be a consequence of the restoration of Akt signaling
and may also contribute to the reparative process.
Based on these encouraging findings, further experiments are
needed to determine whether the effect of estradiol is permanent
or transient since we just analyzed one single time point after
the estradiol administration. In this line, since only male rats
were included in our analysis, it will be important to examine
the effects of PA and estradiol in females, because sex differences
have been reported in the outcomes of different forms of
perinatal brain injuries (Nuñez, 2012). Although these findings
could help to determine a potential new therapeutic target for
neuroprotection in infants, we know that the use of estradiol
as therapeutic treatment is limited by its peripheral hormonal
effects, such as increasing the risk of breast, endometrial, and
ovarian cancer. Therefore, further studies should determine
whether other estrogenic compounds that are free of these
limitations, exert brain reparative actions after PA.
CONCLUSION
Our findings indicate that PA affects one key signaling
pathway that promotes neuroprotection and modulates neuronal
plasticity, the IGF-1R/PI3K/Akt/GSK3β/β catenin signaling
pathway (Figure 6). The rescue of this signaling pathway by
estradiol may contribute to the reparative actions of the hormone
in the hippocampus of adult animals exposed to PA.
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